Klcm Advisors, Inc. Sorrento Therapeutics, Inc. Transaction History

Klcm Advisors, Inc.

  • $758 Million
  • Q1 2024

A detailed history of Klcm Advisors, Inc. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Klcm Advisors, Inc. holds 30,000 shares of SRNE stock, worth $9,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,000
Previous 30,000 -0.0%
Holding current value
$9,900
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024
BUY
N/A
10,000 Added 50.0%
30,000 $9,000
Q1 2023

May 11, 2023
BUY
$0.17 - $1.19 $3,400 - $23,800
20,000 New
20,000 $7,000
Q4 2022

Feb 10, 2023
BUY
$0.74 - $1.83 $14,800 - $36,600
20,000 New
20,000 $17,000

Others Institutions Holding SRNE

# of Institutions
15
Shares Held
5.51M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Klcm Advisors, Inc. Portfolio

Follow Klcm Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email